SCHEMBL1818577

SCHEMBL1818577

COc1ccc(S(=O)(=O)N2CCOc3ccc(-c4ccc(C#N)c(OC)c4)cc32)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.58
▸ CYP2C9 P11712 3/20 0.47
▸ KDM4E B2RXH2 2/20 0.46
▸ PKM P14618 1/20 0.46
▸ PKLR P30613 1/20 0.46
▸ CYP3A4 P08684 3/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ KMT2A Q03164 6/20 0.42
▸ MEN1 O00255 5/20 0.42
▸ MAPT P10636 4/20 0.42
▸ TP53 P04637 1/20 0.42
▸ POLB P06746 2/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ CYP11B1 P15538 1/20 0.42
▸ CYP11B2 P19099 1/20 0.42
▸ USP2 O75604 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ SCN9A Q15858 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1818007 0.92 CYP2C9 (0.56) NPC1CYP2C9KDM4EPKMCYP3A4
SCHEMBL1816318 0.91 NPC1 (0.47) NPC1CYP2C9KDM4EPKMPKLR
SCHEMBL1818967 0.91 CYP2C9 (0.48) NPC1CYP2C9KDM4EPKMPKLR
SCHEMBL1819920 0.91 NPC1 (0.47) NPC1CYP2C9KDM4EPKMPKLR
SCHEMBL1819918 0.91 NPC1 (0.48) NPC1CYP2C9KDM4EPKMPKLR
SCHEMBL1818733 0.90 CYP2C9 (0.47) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1819412 0.90 NPC1 (0.45) NPC1CYP2C9KDM4EPKMPKLR
SCHEMBL1820258 0.89 NPC1 (0.45) NPC1CYP2C9CYP3A4CYP2D6KMT2A
SCHEMBL1817694 0.88 POLB (0.46) NPC1CYP2C9PKMPKLRCYP3A4
SCHEMBL1817219 0.87 NPC1 (0.61) NPC1CYP2C9KDM4EPKMPKLR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO claimed
WO-2011057892-A1 2,3-DIHYDROBENZOXAZINE AND 2,3-DIHYDROBENZOTHIAZINE DERIVATES AS HIF-INHIBITORS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASES ELARA PHARMACEUTICALS GMBH (DE) 2011-05-19 — — WO disclosed
Send feedback